Clementine Delporte, Lore Van Bruwaene, Nicolas Bruffaerts, Elisabeth Rebuffat, Tessa Goetghebuer
{"title":"Wheezing Episodes in Children Before and After the Onset of the COVID-19 Pandemic in Brussels.","authors":"Clementine Delporte, Lore Van Bruwaene, Nicolas Bruffaerts, Elisabeth Rebuffat, Tessa Goetghebuer","doi":"10.1002/ppul.71068","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Studies have demonstrated important changes in the seasonality of pediatric respiratory illnesses since the onset of the COVID-19 pandemic. The aim of this study was to describe the epidemiology of childhood wheezing episodes before and after the start of the COVID-19 pandemic in relation to their potentially associated environmental triggers.</p><p><strong>Methods: </strong>Files of all children treated with salbutamol for an acute wheezing episode in September and October 2019, 2020, and 2021 were retrospectively reviewed. Infection epidemiology, daily concentrations of air pollutants (NO<sub>2</sub>, O<sub>3</sub>, PM<sub>10</sub>, and PM<sub>2.5</sub>), and fungal spores were collected over the same time period.</p><p><strong>Results: </strong>In 2021, 298 episodes of wheezing were observed compared to 111 in 2020 and 86 in 2019 (p < 0.001). Compared to 2019, children with wheezing in 2021 were significantly older (p < 0.001), less likely to have a history of recurrent wheezing (p < 0.001) and required less hospitalization (p = 0.034). Adenovirus and SARS-CoV-2 were more prevalent in 2021 as compared to 2019 (p < 0.001). The concentration of PM<sub>10</sub>, PM<sub>2.5</sub>, and O<sub>3</sub> was higher in 2021, as compared to both 2019 and 2020 (p < 0.001) while the concentration of NO<sub>2</sub> and airborne spores was lower in 2021 compared to 2019 (p < 0.0001).</p><p><strong>Conclusion: </strong>A threefold increase in wheezing episodes was observed in the autumn post-COVID (2021) compared to pre-COVID (2019) together with very high circulation of SARS-CoV-2 and a significant increase of PM<sub>10</sub>, PM<sub>2.5</sub>, and O<sub>3.</sub></p>","PeriodicalId":19932,"journal":{"name":"Pediatric Pulmonology","volume":"60 4","pages":"e71068"},"PeriodicalIF":2.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Pulmonology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ppul.71068","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Studies have demonstrated important changes in the seasonality of pediatric respiratory illnesses since the onset of the COVID-19 pandemic. The aim of this study was to describe the epidemiology of childhood wheezing episodes before and after the start of the COVID-19 pandemic in relation to their potentially associated environmental triggers.
Methods: Files of all children treated with salbutamol for an acute wheezing episode in September and October 2019, 2020, and 2021 were retrospectively reviewed. Infection epidemiology, daily concentrations of air pollutants (NO2, O3, PM10, and PM2.5), and fungal spores were collected over the same time period.
Results: In 2021, 298 episodes of wheezing were observed compared to 111 in 2020 and 86 in 2019 (p < 0.001). Compared to 2019, children with wheezing in 2021 were significantly older (p < 0.001), less likely to have a history of recurrent wheezing (p < 0.001) and required less hospitalization (p = 0.034). Adenovirus and SARS-CoV-2 were more prevalent in 2021 as compared to 2019 (p < 0.001). The concentration of PM10, PM2.5, and O3 was higher in 2021, as compared to both 2019 and 2020 (p < 0.001) while the concentration of NO2 and airborne spores was lower in 2021 compared to 2019 (p < 0.0001).
Conclusion: A threefold increase in wheezing episodes was observed in the autumn post-COVID (2021) compared to pre-COVID (2019) together with very high circulation of SARS-CoV-2 and a significant increase of PM10, PM2.5, and O3.
期刊介绍:
Pediatric Pulmonology (PPUL) is the foremost global journal studying the respiratory system in disease and in health as it develops from intrauterine life though adolescence to adulthood. Combining explicit and informative analysis of clinical as well as basic scientific research, PPUL provides a look at the many facets of respiratory system disorders in infants and children, ranging from pathological anatomy, developmental issues, and pathophysiology to infectious disease, asthma, cystic fibrosis, and airborne toxins. Focused attention is given to the reporting of diagnostic and therapeutic methods for neonates, preschool children, and adolescents, the enduring effects of childhood respiratory diseases, and newly described infectious diseases.
PPUL concentrates on subject matters of crucial interest to specialists preparing for the Pediatric Subspecialty Examinations in the United States and other countries. With its attentive coverage and extensive clinical data, this journal is a principle source for pediatricians in practice and in training and a must have for all pediatric pulmonologists.